These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20052267)

  • 1. Detection of Mycolactone A/B in Mycobacterium ulcerans-Infected Human Tissue.
    Sarfo FS; Phillips RO; Rangers B; Mahrous EA; Lee RE; Tarelli E; Asiedu KB; Small PL; Wansbrough-Jones MH
    PLoS Negl Trop Dis; 2010 Jan; 4(1):e577. PubMed ID: 20052267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence.
    Mve-Obiang A; Lee RE; Portaels F; Small PL
    Infect Immun; 2003 Feb; 71(2):774-83. PubMed ID: 12540557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease.
    Sarfo FS; Phillips RO; Zhang J; Abass MK; Abotsi J; Amoako YA; Adu-Sarkodie Y; Robinson C; Wansbrough-Jones MH
    BMC Infect Dis; 2014 Apr; 14():202. PubMed ID: 24731247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcer.
    Tobias NJ; Seemann T; Pidot SJ; Porter JL; Marsollier L; Marion E; Letournel F; Zakir T; Azuolas J; Wallace JR; Hong H; Davies JK; Howden BP; Johnson PD; Jenkin GA; Stinear TP
    PLoS Negl Trop Dis; 2009 Nov; 3(11):e553. PubMed ID: 19936295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycolactone diffuses into the peripheral blood of Buruli ulcer patients--implications for diagnosis and disease monitoring.
    Sarfo FS; Le Chevalier F; Aka N; Phillips RO; Amoako Y; Boneca IG; Lenormand P; Dosso M; Wansbrough-Jones M; Veyron-Churlet R; Guenin-Macé L; Demangel C
    PLoS Negl Trop Dis; 2011 Jul; 5(7):e1237. PubMed ID: 21811642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs.
    Hong H; Coutanceau E; Leclerc M; Caleechurn L; Leadlay PF; Demangel C
    PLoS Negl Trop Dis; 2008; 2(10):e325. PubMed ID: 18941518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative boronic acids in the detection of Mycolactone A/B using the thin layer chromatography (f-TLC) method for diagnosis of Buruli ulcer.
    Akolgo GA; Partridge BM; D Craggs T; Amewu RK
    BMC Infect Dis; 2023 Jul; 23(1):495. PubMed ID: 37501134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of wild-type and mycolactone-negative mutant Mycobacterium ulcerans on skeletal muscle: IGF-1 protects against mycolactone-induced muscle catabolism.
    Dufresne SS; Frenette J
    Am J Physiol Regul Integr Comp Physiol; 2013 May; 304(9):R753-62. PubMed ID: 23485865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemistry of mycolactones, the causative toxins of Buruli ulcer.
    Kishi Y
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6703-8. PubMed ID: 21383136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant stromal tissue factor localisation and mycolactone-driven vascular dysfunction, exacerbated by IL-1β, are linked to fibrin formation in Buruli ulcer lesions.
    Hsieh LT; Dos Santos SJ; Hall BS; Ogbechi J; Loglo AD; Salguero FJ; Ruf MT; Pluschke G; Simmonds RE
    PLoS Pathog; 2022 Jan; 18(1):e1010280. PubMed ID: 35100311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Mycobacterium species for the presence of a macrolide toxin, mycolactone.
    Daniel AK; Lee RE; Portaels F; Small PL
    Infect Immun; 2004 Jan; 72(1):123-32. PubMed ID: 14688089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence.
    George KM; Chatterjee D; Gunawardana G; Welty D; Hayman J; Lee R; Small PL
    Science; 1999 Feb; 283(5403):854-7. PubMed ID: 9933171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycolactone is responsible for the painlessness of Mycobacterium ulcerans infection (buruli ulcer) in a murine study.
    En J; Goto M; Nakanaga K; Higashi M; Ishii N; Saito H; Yonezawa S; Hamada H; Small PL
    Infect Immun; 2008 May; 76(5):2002-7. PubMed ID: 18316387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple, Rapid Mycobacterium ulcerans Disease Diagnosis from Clinical Samples by Fluorescence of Mycolactone on Thin Layer Chromatography.
    Wadagni A; Frimpong M; Phanzu DM; Ablordey A; Kacou E; Gbedevi M; Marion E; Xing Y; Babu VS; Phillips RO; Wansbrough-Jones M; Kishi Y; Asiedu K
    PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004247. PubMed ID: 26583925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium ulcerans toxic macrolide, mycolactone modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo.
    Adusumilli S; Mve-Obiang A; Sparer T; Meyers W; Hayman J; Small PL
    Cell Microbiol; 2005 Sep; 7(9):1295-304. PubMed ID: 16098217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced Synthesis of Mycolactone Restores the Pathogenesis of
    Strong E; Hart B; Wang J; Orozco MG; Lee S
    Front Immunol; 2022; 13():750643. PubMed ID: 35401531
    [No Abstract]   [Full Text] [Related]  

  • 17. Adhesion of the ulcerative pathogen Mycobacterium ulcerans to DACC-coated dressings.
    Geroult S; Phillips RO; Demangel C
    J Wound Care; 2014 Aug; 23(8):417-8, 422-4. PubMed ID: 25139600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin-specific antibodies neutralizing mycolactone toxin during the spontaneous healing of
    Foulon M; Pouchin A; Manry J; Khater F; Robbe-Saule M; Durand A; Esnault L; Delneste Y; Jeannin P; Saint-André JP; Croué A; Altare F; Abel L; Alcaïs A; Marion E
    Sci Adv; 2020 Feb; 6(9):eaax7781. PubMed ID: 32133396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease.
    Sarfo FS; Phillips R; Wansbrough-Jones M; Simmonds RE
    Cell Microbiol; 2016 Jan; 18(1):17-29. PubMed ID: 26572803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycolactone cytotoxicity in Schwann cells could explain nerve damage in Buruli ulcer.
    En J; Kitamoto S; Kawashima A; Yonezawa S; Kishi Y; Ishii N; Goto M
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005834. PubMed ID: 28783752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.